Biosimilars in IBD: What Every Clinician Needs to Know
Anthony Angyal, Shubha Bhat
Topics & Concepts
BiosimilarMedicineUstekinumabInfliximabInflammatory bowel diseaseAdalimumabVedolizumabIntensive care medicineDiseaseInternal medicineBiosimilars and Bioanalytical MethodsHealth Systems, Economic Evaluations, Quality of LifePharmaceutical studies and practices